Trifluridine/tipiracil increases survival rates in peritoneal dissemination mouse models of human colorectal and gastric cancer

Mostrar otras versiones (1)

A number of patients exhibit peritoneal dissemination of gastric or colorectal cancer, which is a predominant cause of cancer-associated mortality. Currently, there is no markedly effective treatment available. The present study was designed to determine the efficacy of trifluridine/tipiracil (TFTD)...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Norihiko, Nakagawa, Fumio, Takechi, Teiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494646/
https://www.ncbi.nlm.nih.gov/pubmed/28693216
http://dx.doi.org/10.3892/ol.2017.6258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494646/
https://www.ncbi.nlm.nih.gov/pubmed/28693216
http://dx.doi.org/10.3892/ol.2017.6258

Ejemplares similares